100 related articles for article (PubMed ID: 16629484)
1. [Molecular pathogenesis of multiple myeloma].
Iida S
Rinsho Ketsueki; 2006 Mar; 47(3):196-203. PubMed ID: 16629484
[No Abstract] [Full Text] [Related]
2. ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.
Suzuki A; Iida S; Kato-Uranishi M; Tajima E; Zhan F; Hanamura I; Huang Y; Ogura T; Takahashi S; Ueda R; Barlogie B; Shaughnessy J; Esumi H
Oncogene; 2005 Oct; 24(46):6936-44. PubMed ID: 16044163
[TBL] [Abstract][Full Text] [Related]
3. CD221 (IGF-1R) is aberrantly expressed in multiple myeloma, in relation to disease severity.
Bataille R; Robillard N; Avet-Loiseau H; Harousseau JL; Moreau P
Haematologica; 2005 May; 90(5):706-7. PubMed ID: 15921396
[TBL] [Abstract][Full Text] [Related]
4. A novel transgenic mouse model of the human multiple myeloma chromosomal translocation t(14;16)(q32;q23).
Morito N; Yoh K; Maeda A; Nakano T; Fujita A; Kusakabe M; Hamada M; Kudo T; Yamagata K; Takahashi S
Cancer Res; 2011 Jan; 71(2):339-48. PubMed ID: 21224354
[TBL] [Abstract][Full Text] [Related]
5. One translocation for 2 lymphoid neoplasms.
Aussedat G; Baseggio L
Blood; 2019 Jan; 133(2):180. PubMed ID: 30630847
[No Abstract] [Full Text] [Related]
6. Mott cells in CD20-positive myeloma.
Ramasamy K; Ladon D; Salisbury J; Ireland R
Br J Haematol; 2011 Feb; 152(4):366. PubMed ID: 21265822
[No Abstract] [Full Text] [Related]
7. The t(14;20)(q32;q12): a rare cytogenetic change in multiple myeloma associated with poor outcome.
Vekemans MC; Lemmens H; Delforge M; Doyen C; Pierre P; Demuynck H; Bries G; Lemmens J; Meeus P; Straetmans N; Bauwens D; Vidrequin S; Rack K; Vandenberghe P; Wlodarska I; Michaux L
Br J Haematol; 2010 Jun; 149(6):901-4. PubMed ID: 20148877
[No Abstract] [Full Text] [Related]
8. [Identification of gene aberrations involved in the pathogenesis of multiple myeloma].
Iida S; Ueda R
Rinsho Ketsueki; 2000 May; 41(5):408-13. PubMed ID: 10879101
[No Abstract] [Full Text] [Related]
9. Bortezomib in combination with dexamethasone for a young multiple myeloma with t(8; 14).
Li JY; Wang LX; Shen WY; Lu SF; Chen LJ; Lu H
Leuk Res; 2009 Apr; 33(4):584-6. PubMed ID: 18829108
[No Abstract] [Full Text] [Related]
10. Atypical FOXP1 expression in malignant plasma cells that show several simultaneous translocations.
Korać P; Skrtić A; Peran I; Ventura RA; Dominis M
Histopathology; 2009 May; 54(6):770-1. PubMed ID: 19438754
[No Abstract] [Full Text] [Related]
11. [Close correlations between CD20 expression, a small mature plasma cell morphology and t(11 ; 14) in multiple myeloma].
Matsuda I; Mori Y; Nakagawa Y; Sawanobori M; Uemura N; Suzuki K
Rinsho Ketsueki; 2005 Dec; 46(12):1293-7. PubMed ID: 16447802
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in multiple myeloma: it's in the genes.
Bergsagel PL
Clin Cancer Res; 2003 Feb; 9(2):533-4. PubMed ID: 12576415
[No Abstract] [Full Text] [Related]
13. Multiple myeloma: evolving genetic events and host interactions.
Kuehl WM; Bergsagel PL
Nat Rev Cancer; 2002 Mar; 2(3):175-87. PubMed ID: 11990854
[TBL] [Abstract][Full Text] [Related]
14. Deciding on the therapy of multiple myeloma using genetic risk stratification.
Gertz MA
Leuk Lymphoma; 2011 Feb; 52(2):157-8. PubMed ID: 21261501
[No Abstract] [Full Text] [Related]
15. Haematological cancer: abnormal chromosomes forecast rapid disease progression in SMM.
Errico A
Nat Rev Clin Oncol; 2013 Dec; 10(12):671. PubMed ID: 24217203
[No Abstract] [Full Text] [Related]
16. Many and multiple myeloma(s).
Fonseca R
Leukemia; 2003 Oct; 17(10):1943-4. PubMed ID: 14513042
[No Abstract] [Full Text] [Related]
17. MB4-2 breakpoint in MMSET combined with del(17p) defines a subset of t(4;14) multiple myeloma with very poor prognosis.
Lazareth A; Song XY; Coquin A; Harel S; Karlin L; Belhadj K; Roos-Weil D; Frenzel L; Tamburini J; Macro M; Chevret S; Loiseau HA; Minvielle S; Fermand JP; Soulier J; Bories JC; Arnulf B
Haematologica; 2015 Nov; 100(11):e471-4. PubMed ID: 26206803
[No Abstract] [Full Text] [Related]
18. IgM myeloma with t(4;14)(p16;q32).
Ackroyd S; O'Connor SJ; Rawstron AC; Owen RG
Cancer Genet Cytogenet; 2005 Oct; 162(2):183-4. PubMed ID: 16213370
[No Abstract] [Full Text] [Related]
19. A new MAFia in cancer.
Eychène A; Rocques N; Pouponnot C
Nat Rev Cancer; 2008 Sep; 8(9):683-93. PubMed ID: 19143053
[TBL] [Abstract][Full Text] [Related]
20. Dutcher bodies in multiple myeloma are highly associated with translocation t(4;14) and IgA isotype.
Jiang N; Qi C; Chang H
Br J Haematol; 2015 Dec; 171(5):890-2. PubMed ID: 25907777
[No Abstract] [Full Text] [Related]
[Next] [New Search]
